Amino acid replacement: H1869Y.
In addition to the H1869Y amino acid replacement, which may cause the mutant phenotype, a number of additional amino acid changes are present compared to the U34925 mei-41 GenBank sequence (these "common" mutations are also present in other mei-41 mutant alleles, possibly due to variability present in the mutagenised population).
Nucleotide substitution: C8053T.
C16398044T
C8053T
H2032Y | mei-41-PA
H1869Y
The mutation site reported in FBrf0160718 is relative to GB:U34925 (in which the predicted CDS is missing 163 N-terminal amino acids relative to genome release 3.2). Other amino acid changes common to several mei-41 mutants are also present in the strain (see FBrf0160718).
Irradiated homozygous embryos derived from homozygous embryos do not show a reduction in the number of mitotic cells in the dorsal ectoderm 20 minutes after irradiation, in contrast to wild-type embryos, which show a reduction in the number of mitotic cells after irradiation. Wild-type embryos show an increase in the ratio of metaphase to (anaphase+telophase) 40 minutes after irradiation, compared to unirradiated controls. This increase is severely diminished in homozygous embryos derived from homozygous females. 97% of eggs derived from homozygous females hatch into larvae. Hemizygous larvae show 63% loss of the G2/M checkpoint (this number is the average number of mitotic cells per eye disc after exposure of male hemizygous larvae to 500R of X rays expressed as a percentage of the number of mitotic cells per eye disc before irradiation, wild-type values range from 5 to 15%).
Homozygotes and hemizygotes do not show an increased frequency of spontaneous chromosome aberrations in neuroblast metaphases compared to wild-type larvae.
Does not reduce meiotic exchange.
mei-41D12 maps to 12A1-12A7 by deficiency mapping.